Walleye Trading
LEGN icon

Walleye Trading’s Legend Biotech LEGN Stock Holding History

Walleye Trading’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,744
Closed -$231K – 4251
2026
Q1 		$231K Buy
12,744
+7,886
+162% +$150K ﹤0.01% 3040
2025
Q4 		$106K Buy
4,858
+1,352
+39% +$38.7K ﹤0.01% 3715
2025
Q3 		$114K Buy
+3,506
New +$129K ﹤0.01% 3655
2025
Q2 		– Sell
-1,796
Closed -$58.2K – 4489
2025
Q1 		$60.9K Sell
1,796
-930
-34% -$33.4K ﹤0.01% 3560
2024
Q4 		$88.7K Buy
+2,726
New +$113K ﹤0.01% 3594
2023
Q4 		– Sell
-2,302
Closed -$146K – 5304
2023
Q3 		$155K Buy
+2,302
New +$160K ﹤0.01% 3762

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Walleye Trading's LEGN Position: Q2 2026 in Review

Walleye Trading sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 12,744 shares — an estimated $231K sold.

Walleye Trading first reported a position in LEGN in Q3 2023 and held it in 6 quarters. The position peaked at $231K in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Walleye Trading reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 12,744 Legend Biotech shares in Q2 2026, an estimated $231K.
  • Walleye Trading first reported a position in Legend Biotech in Q3 2023 and held it in 6 quarters.
  • Walleye Trading's Legend Biotech position peaked at $231K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.